Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 3(20), p. 198-200, 2020
DOI: 10.1016/j.clml.2019.12.013
Links
Tools
Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Journal article published in 2020 by
Meghan Salcedo,
Nikoletta Lendvai 
,
Donna Mastey,
Julia Schlossman ,
Malin Hultcrantz,
Neha Korde,
Sham Mailankody,
Alexander Lesokhin ,
Hani Hassoun ,
Eric Smith,
Urvi Shah ,
Victoria Diab,
Kelly Werner,
Heather Landau ,
Oscar Lahoud
and other authors.
,
Donna Mastey,
Julia Schlossman ,
Malin Hultcrantz,
Neha Korde,
Sham Mailankody,
Alexander Lesokhin ,
Hani Hassoun ,
Eric Smith,
Urvi Shah ,
Victoria Diab,
Kelly Werner,
Heather Landau ,
Oscar Lahoud
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 